These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 169214)

  • 1. Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with their membrane receptors.
    Bataille D; Rosselin G; Freychet P
    Isr J Med Sci; 1975 Jul; 11(7):687-92. PubMed ID: 169214
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with liver and fat cell plasma membranes: binding to specific sites and stimulation of adenylate cyclase.
    Bataille D; Freychet P; Rosselin G
    Endocrinology; 1974 Sep; 95(3):713-21. PubMed ID: 4368831
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions of glucagon and related peptides with chicken adipose tissue.
    Kitabgi P; Rosselin G; Bataille D
    Horm Metab Res; 1976 Jul; 8(4):266-70. PubMed ID: 182629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interaction of gastrointestinal hormones with pancreatic cells in the rat].
    Robberecht P; Deschodt-Lanckman M; De Neef P; Christophe J
    Arch Int Physiol Biochim; 1974 Feb; 82(1):196. PubMed ID: 4136391
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of secretin, glucagon and vasoactive intestinal peptide on the hormone-sensitive rat cardiac adenylate cyclase [proceedings].
    Chatelain P; Deschodt-Lanckman M; De Neef P; Christophe J; Robberecht P
    Arch Int Physiol Biochim; 1979 Oct; 87(4):783-4. PubMed ID: 93901
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone receptors - their function in cell membranes and some problems related to methodology.
    Cuatrecasas P
    Adv Cyclic Nucleotide Res; 1975; 5():79-104. PubMed ID: 165699
    [No Abstract]   [Full Text] [Related]  

  • 7. [Membrane receptors of vasoactive intestinal peptide (VIP): hormone and neurotransmitter (proceedings)].
    Robberecht P
    Arch Int Physiol Biochim; 1978 Oct; 86(4):842-3. PubMed ID: 84566
    [No Abstract]   [Full Text] [Related]  

  • 8. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
    Birnbaum RS; Alfonzo M; Kowal J
    Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
    Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
    Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of hormone receptors.
    Rodbell M
    Neurosci Res Program Bull; 1973 Jun; 11(3):211-5. PubMed ID: 4351989
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of human adenylate cyclase in the upper gastrointestinal tract by vasoactive intestinal polypeptide.
    Simon B; Kather H
    Gastroenterology; 1978 Apr; 74(4):722-5. PubMed ID: 204535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glucagon receptor and its relationship to adenylate cyclase.
    Pohl SL
    Fed Proc; 1977 Jul; 36(8):2115-8. PubMed ID: 194799
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of vasoactive intestinal peptide, secretin, and related peptides on rat colonic transport and adenylate cyclase activity.
    Waldman DB; Gardner JD; Zfass AM; Makhlouf GM
    Gastroenterology; 1977 Sep; 73(3):518-23. PubMed ID: 892349
    [No Abstract]   [Full Text] [Related]  

  • 14. [Glucagon receptors].
    Desbuquois B
    Ann Biol Clin (Paris); 1976; 34(5):371-3. PubMed ID: 189643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of enteric hormones in glucose homeostasis.
    Buchanan KD
    Horm Metab Res; 1976; Suppl 6():80-4. PubMed ID: 1278842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats.
    Soman V; Felig P
    J Clin Invest; 1978 Mar; 61(3):552-60. PubMed ID: 205552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational considerations in the design of glucagon agonists and antagonists: examination using synthetic analogs.
    Hruby VJ; Krstenansky J; Gysin B; Pelton JT; Trivedi D; Mckee RL
    Biopolymers; 1986; 25 Suppl():S135-55. PubMed ID: 3022837
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipolytic action of a newly isolated vasoactive intestinal polypeptide.
    Frandsen EK; Moody AJ
    Horm Metab Res; 1973 May; 5(3):196-9. PubMed ID: 4714546
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasoactive intestinal polypeptide and glucagon: stimulation of adenylate cyclase activity via distinct receptors in liver and fat cell membranes.
    Desbuguois B; Laudat MH; Laudat P
    Biochem Biophys Res Commun; 1973 Aug; 53(4):1187-94. PubMed ID: 4356054
    [No Abstract]   [Full Text] [Related]  

  • 20. Speculations on the mechanism of hormone-receptor interactions of the secretin/glucagon family of polypeptide hormones derived from computational structural studies.
    Momany FA; Bowers CY
    Ann N Y Acad Sci; 1996 Dec; 805():172-81; discussion 181-3. PubMed ID: 8993402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.